SUPERSTRING CAPITAL MANAGEMENT LP
CIK 1931118 · Holdings on Sep 30, 2024 · First reported Nov 14, 2024
Top ten holdings
Q3 2024- ZLAB13.53%
- CYTK10.19%
- TERN10.06%
- GPCR8.91%
- ORIC8.70%
- TIL6.47%
- NVCR5.49%
- BBIO5.16%
- FATE4.59%
- CAPR4.59%
Share classes counted separately77.69%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- ZLABWeight increased · +8.83 pp4.70% → 13.53%Shares +411.75K (+191.36%)
- LEGNWeight decreased · -6.00 pp8.64% → 2.64%Shares -94.15K (-60.87%)
- NVCRWeight increased · +4.05 pp1.44% → 5.49%Shares +325.82K (+487.08%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 27
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | ZLABZAI LAB LTD-ADRADR View history and evidence | $15.13M | 13.53% | 626.93K shares | 4.70% → 13.53%+8.83 pp +411.75K (+191.36%) | Added | ↗▾ |
| 02 | CYTKCYTOKINETICS INCCOM NEW View history and evidence | $11.39M | 10.19% | 215.80K shares | 12.81% → 10.19%-2.62 pp +28.16K (+15.01%) | Added | ↗▾ |
| 03 | TERNTERNS PHARMACEUTICALS INC View history and evidence | $11.25M | 10.06% | 1.35M shares | 8.21% → 10.06%+1.85 pp +392.00K (+40.98%) | Added | ↗▾ |
| 04 | GPCRSTRUCTURE THERAPEUTICS INCSPONSORED ADS View history and evidence | $9.97M | 8.91% | 227.05K shares | Prior unavailable +227.05K | New | ↗▾ |
| 05 | ORICORIC PHARMACEUTICALS INC View history and evidence | $9.73M | 8.70% | 949.52K shares | Prior unavailable +949.52K | New | ↗▾ |
| 06 | TILINSTIL BIO INCCOM NEW View history and evidence | $7.24M | 6.47% | 107.55K shares | Prior unavailable +107.55K | New | ↗▾ |
| 07 | NVCRNOVOCURE LTDORD SHS View history and evidence | $6.14M | 5.49% | 392.71K shares | 1.44% → 5.49%+4.05 pp +325.82K (+487.08%) | Added | ↗▾ |
| 08 | BBIOBRIDGEBIO PHARMA INC View history and evidence | $5.77M | 5.16% | 226.68K shares | 7.02% → 5.16%-1.86 pp +6.85K (+3.11%) | Added | ↗▾ |
| 09 | FATEFATE THERAPEUTICS INC View history and evidence | $5.13M | 4.59% | 1.47M shares | 2.06% → 4.59%+2.53 pp +969.57K (+194.94%) | Added | ↗▾ |
| 10 | CAPRCAPRICOR THERAPEUTICS INCCOM NEW View history and evidence | $5.13M | 4.59% | 337.35K shares | Prior unavailable +337.35K | New | ↗▾ |
Options overlay 1
$2.41M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
ZLABZAI LAB LTD-ADRADR View history and evidence | Call | 100.00K | $2.41M | +100.00K | ▾ |
1 / 1 options · preview only
Exited positions 20
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| KROS KEROS THERAPEUTICS INC | Non-derivative | -74,288 | -$3.39M | SEC filing ↗ | SEC filing ↗ |
| ACLX ARCELLX INC | Non-derivative | -59,133 | -$3.26M | SEC filing ↗ | SEC filing ↗ |
| ARWR ARROWHEAD PHARMACEUTICALS IN | Non-derivative | -111,133 | -$2.89M | SEC filing ↗ | SEC filing ↗ |
3 / 20 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1931118 · Period 2024-09-30
Data loaded 2026-09-23 · First reported 2024-11-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 114247624
}Take these holdings further.
This page includes 28 of 28 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 28 of 28 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1931118","quarter":"2024Q3","page_size":100}
get_institutional_manager_history
{"cik":"1931118","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.